Local recurrence after glans‐sparing surgery: no impact on penile cancer‐specific survival

Patients undergoing GSS for PSCC demonstrate excellent survival outcomes, despite LR in 29% of men. These findings support the use of GSS as a safe and effective treatment option for patients committed to adequate follow-up.

Authors

Institutions

Publication Details

Journal
British Journal of Urology
Published
2025-11-03
DOI
https://doi.org/10.1111/bju.70055
Primary Topic
Genital Health and Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Local recurrence after glans‐sparing surgery: no impact on penile cancer‐specific survival

Giuseppe Basile, Sebastiano Nazzani, Eduard Roussel, Georgios Hatzichristodoulou et al.
British Journal of Urology
Genital Health and Disease
article

Local recurrence after glans‐sparing surgery: no impact on penile cancer‐specific survival

Giuseppe Basile, Sebastiano Nazzani, Eduard Roussel, Georgios Hatzichristodoulou, Oscar Roberto Brouwer, N. Nardo, Christian D. Fankhauser, Marija Miletić, Philippe E. Spiess, Nick Watkin, Andrea Salonia, Robert M. Verdijk, Hielke‐Martijn De Vries, Benjamin Ayres, Marco Bandini, Arie Parnham, Nicola Nicolai, Davide Perri, Hussain M. Alnajjar, Laura Elst, Giorgio Bozzini, Asıf Muneer, João Lobo, Maarten Albersen, Richard Barry Sirard, Marco Falcone, Arshpreet Kaur, Sylvia Yan, Alberto Breda
article en

Abstract

Patients undergoing GSS for PSCC demonstrate excellent survival outcomes, despite LR in 29% of men. These findings support the use of GSS as a safe and effective treatment option for patients committed to adequate follow-up.

British Journal of UrologyVol. 137(1)
Vita-Salute San Raffaele University (IT), University of Lucerne (CH), Universidade do Porto (PT), University of Zurich (CH), Rega Institute for Medical Research (BE), University of South Florida (US), Universitair Ziekenhuis Leuven (BE), St George’s University Hospitals NHS Foundation Trust (GB), The Netherlands Cancer Institute (NL), Moffitt Cancer Center (US), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Fondazione Ricerca Molinette (IT), Mercy University Hospital (IE), Instituto Português de Oncologia Francisco Gentil (PT), Biruni University (TR), IPO Porto (PT), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL), IRCCS Ospedale San Raffaele (IT), The Christie NHS Foundation Trust (GB), UCL Biomedical Research Centre (GB), Martha-Maria Hospital (DE), Puigvert Foundation (ES), The London College (GB), Ospedale Sant'Anna (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), University College London (GB), KU Leuven (BE)
Openalex Percentile: Top 50%
Genital Health and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.